Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende Patientenratgeber
Erweiterte Suche
Anmelden
nach oben
Current HIV/AIDS Reports
Erschienen in:

22.10.2016 | Behavioral-Bio-Medical Interface (JL Brown and RJ DiClemente, Section Editors)

HIV and Aging Research in Women: An Overview

verfasst von: David M. Stoff, Deborah Colosi, Anna Rubtsova, Gina Wingood

Erschienen in: Current HIV/AIDS Reports | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

This paper reviews some background issues as a foundation to place the ensuing supplement papers of this special issue section in context. The articles in this special supplement issue deepen and expand our understanding of biomedical, neurocognitive, and psychosocial aspects involved in human immunodeficiency virus (HIV) of older women, primarily through the use of the Women’s Interagency HIV Study (WIHS) prospective cohort study. As it relates to research on the intersection between HIV and aging in women, we discuss (i) epidemiology as introduction, (ii) the cohort study design featuring the WIHS, (iii) definitions, (iv) models, and (v) section articles.
Literatur
1.
Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, Cases of HIV infection and AIDS in the United States, December 1985. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention
2.
Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. Cases of HIV infection and AIDS in the United States. 1999, vol 11, No. 2. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention
3.
Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. Cases of HIV infection and AIDS in the United States, 2003, vol. 15. Atlanta: US Department of Health and Human Services
4.
Centers for Disease Control and Prevention (CDC). Centers for Disease Control and Prevention (CDC). Estimated HIV incidence in the United States, 2007–2010. HIV Surveillance Supplemental Report. 2012;17(4):1–26.
5.
Hall HI, Frazier EL, Rhodes P, Hotgrave DR, Furlow-Parmley C, Tang T, et al. Differences in human immunodeficiency virus care and treatment among subpopulations in the United States. JAMA Intern Med. 2013;173(14):1337–44.CrossRefPubMed
6.
Lansky A, Hall I, Mermin J. Declining HIV incidence among women in the United States. Women’s Health Issues. 2014;24(6):581–3.CrossRefPubMed
7.•
8.
Earnshaw VA, Bogart LM, Dovidio JF, Williams DR. Stigma and racial/ethnic HIV disparities: moving toward resilience. Am Psychol. 2013;68(4):225–36.CrossRefPubMedPubMedCentral
9.
McDavid K, Li J, Lee LM. Racial and ethnic disparities in HIV diagnoses for women in the United States. J Acquir Immune Defic Syndr. 2006;42(1):101–7.CrossRefPubMed
10.•
11.
Brooks JT, Buchacz K, Gebo KA, Mermin J. HIV infection and older Americans: the public health perspective. Am J Public Health. 2012;102:1516–26.CrossRefPubMedPubMedCentral
12.
Mills EJ, Barnighausen T, Negin J. HIV and aging—preparing for the challenges ahead. N Engl J Med. 2012;366:1270–3.CrossRefPubMed
13.
14.
Centers for Disease Control and Prevention. Diagnoses of HIV infection among adults aged 50 years and older in the United States and dependent areas. 2007-2010. HIV Surveillance Supplemental. 2013;18:Number 3.
15.
16.
Ellman TM, Sexton ME, Warshafsy D, Sobieszczyk ME, Morrison EAB. A forgotten population: older adults with newly diagnosed HIV. AIDS Patient Care STDs. 2014;28(10):530–6.CrossRefPubMed
17.••
Rueda S, Law S, Rourke SB. Psychosocial, mental health, and behavioral issues of aging with HIV. Curr Opin HIV AIDS. 2014;9:325–31. Review that describes the recent evidence exploring the psychosocial challenges facing older adults living with HIV.CrossRefPubMed
18.
Ettenhofer ML, Hinkin CH, Castellon SA, Durvasula R, Ullman J, Lam M, et al. Aging, neurocognition, and medication adherence in HIV infection. Am J Geriatr Psychiatry. 2009;17(4):281–90.CrossRefPubMedPubMedCentral
19.
20.••
Guaraldi G, Zona S, Brothers TD, Carli F, Stentarelli C, Dolci G, et al. Aging with HIV vs. HIV seroconversion at older age: a diverse population with distinct comorbidity profiles. PLoS ONE. 2015;10(4):e0118531. Case-control study that assesses the prevalence of, and risk factors for, individual comorbidities and multimorbidity (MM) between HIV-positive patients with a longer duration of HIV infection and patients who seroconverted at an older age. Prevalence of HIV comorbidities and MM were significantly higher in the HIV-positive groups compared to the general population (p < 0.001), and a trend toward higher rates of MM was found in aging vs aged group.
21.
Bacon MC, von Wyl V, Alden C, et al. The Women’s Interagency HIV Study: an observational cohort brings clinical sciences to the bench. Clin Diagn Lab Immunol. 2005;12:1013–9.PubMedPubMedCentral
22.
Samet JM, Munoz A. Evolution of the Cohort Study. Epidemiol Rev. 1999;20(1):1–136.CrossRef
23.
Gange, S (unpublished data, 2016; Tables taken from WIHS Report prepared by WIHS Data Management and Analysis Center, Women’s Interagency HIV Study, Semiannual Executive Committee Meeting, May 17-19, 2016, Rockville, MD)
24.
Sankar A, Nevedal A, Neufeld S, Berry R, Luborsky M. What do we know about older adults and HIV? A review of social and behavioral literature. AIDS Care. 2011;23:1187–207.CrossRefPubMedPubMedCentral
25.
Shafer MH, Shippee TP. Age identify in context: stress and the subjective side of aging. Soc Psychol Quart. 2010;73:245–64.CrossRef
26.
Clark DO, Frankel RM, Morgan DL. The meaning and significance of self management among socioeconomically vulnerable older adults. J Gerontol B Psychol Sci Soc Sci. 2008;63:S312–9.CrossRefPubMedPubMedCentral
27.••
Warren-Jeanpiere L, Dillaway H, Hamilton P, Young M, Goparaju L. Taking it one day at a time: African American women aging with HIV and co-morbidities. AIDS Patient Care STDs. 2014;28(7):372–80. Focus groups were conducted with HIV-positive African American women aged 52–65 on topics including HIV and comorbidity self-management, social support needs, medication adherence, and future plans for old age. Overall, this study demonstrates that HIV and comorbidity self-management are inextricably linked.
28.
Fry C. Anthropological themes of age and aging. In: Bengston V, Schaie K, editors. Handbook of theories and aging. New York: Springer; 1999. p. 271–96.
29.
Hareven T. Family time and industrial time. New York: University Press of America; 1993.
30.
Brandstader J. Development as a personal and cultural construction. In: Semin G, Gergen K, editors. Everyday understanding: social and scientific implications. Newbury Park: Sage Publications; 1990.
31.
Fried L, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol Med Sci. 2001;56A:M146–56.CrossRef
32.••
Gustafson DR, Shi Q, Thurn M, Holman S, Minkoff H, Cohen M, et al. Frailty and constellations of factors in aging HIV-infected and uninfected women—the Women’s Interagency HIV Study. J Frailty Aging. 2016;5(1):43–8. Cross-sectional study that explored age-adjusted prevalence of frailty, a geriatric condition, among HIV+ and at-risk HIV women. This study found that frailty is a multidimensional aging phenotype observed in mid-life among women with HIV infection. Prevalence of frailty in this sample of HIV-infected women exceeds that for usual elderly populations.
33.••
Woods NF, Cochrane BB, LaCroix AZ, Seguin RA, Zaslavsky O, Liu J, et al. Toward a positive aging phenotype for older women: observations from the Women’s Health Initiative. J Gerontol A Biol Sci Med Sci. 2012;67(11):1191–6. Data from Women’s Health Initiative clinical trial and observational study participants aged 65 years and older at baseline, including follow-up observations up to 8 years later, were analyzed using descriptive statistics and principal component analysis to identify the factor structure of a positive aging phenotype. Findings identified a multidimensional phenotype of positive aging that included two factors: physical-social functioning and emotional functioning; both factors were predictive of each of the outcomes, but physical-social functioning was the stronger predictor.
34.•
Goodkin K, Stoff DM, Jeste DV and Marquine M. Aging with HIV. In: Cohen MA. Goprman JM, Jacobson JM, Volberding P and Letendre S (Eds). Comprehensive Textbook of AIDS Psychiatry—a Paradigm for Integrated Care. 2016, Oxford University Press (in press). This comprehensive chapter current reviewed several research areas in HIV-infection/aging including conceptualization, identification and verification of phenotypes as sub-groups of older persons with HIV infection, HIV prevention and treatment approaches, HAND, other psychiatric disorders, and successful aging.
35.
Pruchno RA, Wilson-Genderson M. A longitudinal examination of the effects of early influences and midlife characteristics on successful aging. J Gerontol B Psychol Sci Soc Sci. 2015;70(6):850–9.CrossRefPubMed
36.
McArdle JJ, Nesselroade JR. Longitudinal data analysis using structural equation models. Washington, DC, US: American Psychological Association; 2014. doi:10.​1037/​14440-000.CrossRef
37.••
Cysique LA, Brew BJ. The effects of HIV and aging on brain functions: proposing a research framework and update on last 3 years’ findings. Curr Opin HIV/AIDS. 2014;9(4):355–64. This review proposes a research framework for HIV and aging studies on brain function to improve the formulation of research questions and findings.
38.
Psaros C, Barinas J, Robbins GK, Bedoya CA, Park ER and Safren SA. Reflections on living with HIV over time: exploring the perspective of HIV-infected women over 50. Aging & Mental Health, 2015 Vol. 19, No. 2, 121-128, Themes and issues, organized into a model of coping with HIV, were identified by this study to help guide interventions across the lifespan for women with HIV.
39.
Rickabaugh TM, Baxter RM, Sehl M, Sinsheimer JS, Hultin PM, Hultin LE, et al. Acceleration of age-associated methylation patterns in HIV-1-infected adults. Plos ONE. 2015;10(3):e0119201.CrossRefPubMedPubMedCentral
40.
41.••
Durvasula R. HIV/AIDS in older women: unique challenges, unmet needs. Behav Med. 2014;40:85–98. This review presents a model and review of the extant literature on older women with HIV/AIDS in the USA to inform prevention, intervention, and best practices with this population of women with attention to such factors as stigma, disclosure, routine HIV testing, and age-related physiological changes on risk and sexual health.
42.
Diez-Roux AV. Multilevel analysis in Public Health research. Annu Rev Public Health. 2000;21:171–92.CrossRefPubMed
43.
Goldstein H. Multilevel statistical models. Oxford: Oxford University Press; 2003.
44.
Karpiak SE, Shippy RA, Cantor M. Research on older adults with HIV. New York: AIDS Community Research Initiative of America; 2006.
45.
Shippy RA, Karpiak SE. Aging HIV/AIDS population: fragile social networks. Aging Mental Health. 2005;9(3):246–54.CrossRefPubMed
46.
Emlet CA. An examination of the social networks and social isolation in older and younger adults living with HIV/AIDS. Health Soc Work. 2006;31(4):299–308.CrossRefPubMed
47.
Scrimshaw EW, Siegel K. Perceived barriers to social support from family and friends among older adults with HIV/AIDS. J Health Psychol. 2003;8(6):738–52.CrossRef
48.••
Centers for Disease Control and Prevention (CDC), 2016. Understanding the HIV care continuum. CDC fact sheet explains the various approaches and data used to develop the HIV care continuum, how it is used to improve outcomes for people living with HIV in the United States and how it helps guide the nation’s response to HIV.
49.
Turan B, Stringer KL, Onono M, Bukusi EA, Weiser SD, Cohen CR, and Turan JM. Linkage to HIV care, postpartum depression, and HIV-related stigma in newly diagnosed pregnant women living with HIV in Kenya: a longitudinal observational study. BMC Pregnancy and Childbirth 2014, 14:400, 1-10
50.••
Horberg MA, Hurley LB, Klein DB, Towner WJ, Kadlecik P, Antoniskis D, et al. The HIV care cascade measured over time and by age, sex, and race in a large national integrated care system. AIDS Patient Care STDs. 2015;29(11):582–90. This study examined HIV cascade stage performance over time and by age, sex, and race/ethnicity. Women had significantly greater retention for all years tested; retention efforts should be targeted toward younger patients and blacks; and women, blacks, and Latinos require greater ART prescribing.
51.
Cheever LW. Engaging HIV-infected patients in care: their lives depend on it. Clin Infect Dis. 2007;44(11):500–1.CrossRef
52.••
Erlandson KM, Schrack JA, Jankowski CM, Brown TT, Campbell TB. Functional impairment, disability, and frailty in adults aging with HIV-infection. Curr HIV/AIDS Rep. 2014;11(3):279–90. This review on functional impairment in HIV-infected older adults distinguished between different terms used to describe function and the corresponding measures, described what is known about function in the aging HIV population, and considered directions for future research in aging with HIV infection.
53.
Solomon P, O’Brien K, Wilkins S, Gervais N. Aging with HIV: a model of disability. J Int Assoc Providers AIDS Care. 2014;13(6):519–25.CrossRef
54.
Vance DE, Fazeli PL, Grant JS, Slater LZ, Raper JL. The role of neuroplasticity and cognitive reserved in aging with HIV: recommendations for cognitive protection and rehabilitation. J Neurosci Nurs. 2013;45(5):306–16.CrossRefPubMedPubMedCentral
55.
Cody SL, Fazeli PL, Vance DE. Feasibility of a home-based speed of processing training program in middle-aged and older adults with HIV. J Neurosci Nurs. 2015;47(4):247–54.CrossRefPubMedPubMedCentral
56.••
Cody SL and Vance DE. The neurobiology of HIV and its impact on cognitive reserve: a review of cognitive interventions for an aging population. Neurobiol Dis. 2016;92(Pt B):144–56. This review examined the neurobiology of HIV and its impact on cognitive reserve in lieu of viral-induced neuroinflammation and neurotoxic substances. The article reviewed the basic cellular mechanisms involved with the neurobiology of HIV, beginning with viral entry into the central nervous system (CNS), disruption of the blood brain barrier (BBB), Tat and other neurotoxic molecules, and the role of microglial cells.
57.
Vance DE. Aging and neurocognitive functioning in HIV-infected women: a review of the literature involving the Women’s Interagency HIV Study. Current HIV/AIDS Reports (2016, Vol 13)
58.
Weitzmann MN, Ofotokun I, Titanji KN, Anjali Sharma A, Yin MT. Bone loss among women living with HIV. Current HIV/AIDS Reports (2016, Vol 13)
59.••
Rubtsova AA, Kempf M-C, Taylor T, Konkle-Parker D, Wingood GM, and Holstad MM. Healthy aging in older women living with HIV infection. Current HIV/AIDS Reports (2016, Vol 13).  This paper reviewed psychosocial research among HIV-infected older women that occurred between 2013 and 2016 in the WIHS and elsewhere.
60.••
Thurn M and Gustafson D. Faces of frailty in aging with HIV infection. Current HIV/AIDS Reports (2016, Vol 13).  This paper presented an overview of frailty definition and assessment and discussed how frailty is being studied in the WIHS.
Metadaten
Titel
HIV and Aging Research in Women: An Overview
verfasst von
David M. Stoff
Deborah Colosi
Anna Rubtsova
Gina Wingood
Publikationsdatum
22.10.2016
Verlag
Springer US
Erschienen in
Current HIV/AIDS Reports / Ausgabe 6/2016
Print ISSN: 1548-3568
Elektronische ISSN: 1548-3576
DOI
https://doi.org/10.1007/s11904-016-0338-4

Weitere Artikel der Ausgabe 6/2016

HIV and Bone Complications: Understudied Populations and New Management Strategies

  • Complications of HIV and Antiretroviral Therapy (G McComsey, Section Editor)

Metabolic and Cardiovascular Complications in HIV/HCV-Co-infected Patients

  • Complications of HIV and Antiretroviral Therapy (G McComsey, Section Editor)

Community-Based ART Programs: Sustaining Adherence and Follow-up

  • Open Access
  • The Global Epidemic (SH Vermund, Section Editor)

Aging of the Liver: What This Means for Patients with HIV

  • Co-infections and Comorbidity (S Naggie, Section Editor)

Frailty in HIV: Epidemiology, Biology, Measurement, Interventions, and Research Needs

  • Complications of HIV and Antiretroviral Therapy (G McComsey, Section Editor)

CNS Impact of Perinatal HIV Infection and Early Treatment: the Need for Behavioral Rehabilitative Interventions Along with Medical Treatment and Care

  • Central Nervous System and Cognition (SS Spudich, Section Editor)

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Lp(a) zur Risikoeinschätzung bei Thoraxschmerzen

Der Lp(a)-Wert kann dazu beitragen, bei stabilen Patienten mit neu aufgetretenen Thoraxschmerzen und ohne KHK-Diagnose die Wahrscheinlichkeit für das Vorliegen von Koronarstenosen abzuschätzen.

Finerenon bei eGFR-Verlust nicht gleich absetzen!

Der Mineralokortikoid-Rezeptor-Antagonist Finerenon verbessert die Prognose bei Herzinsuffizienz mit leicht reduzierter oder erhaltener Ejektionsfraktion. Ein Rückgang der eGFR zu Beginn der Therapie scheint diese Wirkung nicht wesentlich zu mindern.

Polypen bei nahen Verwandten – erhöhtes Darmkrebsrisiko

Werden bei erstgradigen Verwandten gutartige Darmpolypen identifiziert, ist das Risiko, selbst an einem Kolorektalkarzinom zu erkranken, deutlich erhöht – vor allem das für eine früh beginnende Erkrankung. Hier könnte sich eine frühe Koloskopie besonders lohnen.

Verbände und Cremes gegen Dekubitus: „Wir wissen nicht, was sie bringen!“

Die Datenlage zur Wirksamkeit von Verbänden oder topischen Mitteln zur Prävention von Druckgeschwüren sei schlecht, so die Verfasser einer aktuellen Cochrane-Studie. Letztlich bleibe es unsicher, ob solche Maßnahmen den Betroffenen nutzen oder schaden.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Jetzt 10 CME-Punkte sammeln

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise